was read the article
array:24 [ "pii" => "S1578219020301232" "issn" => "15782190" "doi" => "10.1016/j.adengl.2019.06.007" "estado" => "S300" "fechaPublicacion" => "2020-05-01" "aid" => "2293" "copyright" => "AEDV" "copyrightAnyo" => "2020" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "rev" "cita" => "Actas Dermosifiliogr. 2020;111:281-90" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "Traduccion" => array:1 [ "es" => array:20 [ "pii" => "S0001731020300028" "issn" => "00017310" "doi" => "10.1016/j.ad.2019.06.005" "estado" => "S300" "fechaPublicacion" => "2020-05-01" "aid" => "2293" "copyright" => "AEDV" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "rev" "cita" => "Actas Dermosifiliogr. 2020;111:281-90" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "es" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">REVISIÓN</span>" "titulo" => "Revisión de los términos que definen un carcinoma epidermoide cutáneo asociado a mal pronóstico" "tienePdf" => "es" "tieneTextoCompleto" => "es" "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "281" "paginaFinal" => "290" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "A review of terms used to define cutaneous squamous cell carcinoma with a poor prognosis" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "J. Cañueto, A. Tejera-Vaquerizo, P. Redondo, R. Botella-Estrada, S. Puig, O. Sanmartin" "autores" => array:6 [ 0 => array:2 [ "nombre" => "J." "apellidos" => "Cañueto" ] 1 => array:2 [ "nombre" => "A." "apellidos" => "Tejera-Vaquerizo" ] 2 => array:2 [ "nombre" => "P." "apellidos" => "Redondo" ] 3 => array:2 [ "nombre" => "R." "apellidos" => "Botella-Estrada" ] 4 => array:2 [ "nombre" => "S." "apellidos" => "Puig" ] 5 => array:2 [ "nombre" => "O." "apellidos" => "Sanmartin" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S1578219020301232" "doi" => "10.1016/j.adengl.2019.06.007" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219020301232?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731020300028?idApp=UINPBA000044" "url" => "/00017310/0000011100000004/v3_202009220625/S0001731020300028/v3_202009220625/es/main.assets" ] ] "itemSiguiente" => array:20 [ "pii" => "S1578219020300834" "issn" => "15782190" "doi" => "10.1016/j.adengl.2020.04.009" "estado" => "S300" "fechaPublicacion" => "2020-05-01" "aid" => "2292" "copyright" => "AEDV" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "pgl" "cita" => "Actas Dermosifiliogr. 2020;111:291-9" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Consensus Document</span>" "titulo" => "Diagnosis and Treatment of Basal Cell Carcinoma in Specialized Dermatology Units: A Clinical Practice Guideline" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "291" "paginaFinal" => "299" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Carcinoma basocelular cutáneo: diagnóstico y tratamiento en atención especializada dermatológica. Guía de Práctica Clínica de la AEDV" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "F. Vílchez-Márquez, P. Borregón-Nofuentes, L. Barchino-Ortiz, A. Ruíz-de-Casas, I. Palacios-Álvarez, A. Soria-Rivas, M.A. Descalzo-Gallego, I. García-Doval, L. Ríos-Buceta, P. Redondo-Bellón" "autores" => array:10 [ 0 => array:2 [ "nombre" => "F." "apellidos" => "Vílchez-Márquez" ] 1 => array:2 [ "nombre" => "P." "apellidos" => "Borregón-Nofuentes" ] 2 => array:2 [ "nombre" => "L." "apellidos" => "Barchino-Ortiz" ] 3 => array:2 [ "nombre" => "A." "apellidos" => "Ruíz-de-Casas" ] 4 => array:2 [ "nombre" => "I." "apellidos" => "Palacios-Álvarez" ] 5 => array:2 [ "nombre" => "A." "apellidos" => "Soria-Rivas" ] 6 => array:2 [ "nombre" => "M.A." "apellidos" => "Descalzo-Gallego" ] 7 => array:2 [ "nombre" => "I." "apellidos" => "García-Doval" ] 8 => array:2 [ "nombre" => "L." "apellidos" => "Ríos-Buceta" ] 9 => array:2 [ "nombre" => "P." "apellidos" => "Redondo-Bellón" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0001731020300016" "doi" => "10.1016/j.ad.2019.07.006" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731020300016?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219020300834?idApp=UINPBA000044" "url" => "/15782190/0000011100000004/v1_202006060751/S1578219020300834/v1_202006060751/en/main.assets" ] "en" => array:19 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Review</span>" "titulo" => "A review of terms used to define cutaneous squamous cell carcinoma with a poor prognosis" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "281" "paginaFinal" => "290" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "J. Cañueto, A. Tejera-Vaquerizo, P. Redondo, R. Botella-Estrada, S. Puig, O. Sanmartin" "autores" => array:6 [ 0 => array:4 [ "nombre" => "J." "apellidos" => "Cañueto" "email" => array:1 [ 0 => "jcanueto@usal.es" ] "referencia" => array:3 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] 2 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "A." "apellidos" => "Tejera-Vaquerizo" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] ] ] 2 => array:3 [ "nombre" => "P." "apellidos" => "Redondo" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">d</span>" "identificador" => "aff0020" ] ] ] 3 => array:3 [ "nombre" => "R." "apellidos" => "Botella-Estrada" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">e</span>" "identificador" => "aff0025" ] ] ] 4 => array:3 [ "nombre" => "S." "apellidos" => "Puig" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">f</span>" "identificador" => "aff0030" ] ] ] 5 => array:3 [ "nombre" => "O." "apellidos" => "Sanmartin" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">g</span>" "identificador" => "aff0035" ] ] ] ] "afiliaciones" => array:7 [ 0 => array:3 [ "entidad" => "Servicio de Dermatología, Hospital Universitario de Salamanca, Salamanca, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Instituto de Investigación Biomédica de Salamanca (IBSAL), Hospital Universitario de Salamanca, Salamanca, Spain" "etiqueta" => "b" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "Departamento de Dermatología, Instituto Dermatológico GlobalDerm, Palma del Río, Córdoba, Spain" "etiqueta" => "c" "identificador" => "aff0015" ] 3 => array:3 [ "entidad" => "Servicio de Dermatología, Clínica Universitaria de Navarra, Pamplona, Navarra, Spain" "etiqueta" => "d" "identificador" => "aff0020" ] 4 => array:3 [ "entidad" => "Servicio de Dermatología, Hospital Universitario La Fe, Facultad de Medicina, Universidad de Valencia, Valencia, Spain" "etiqueta" => "e" "identificador" => "aff0025" ] 5 => array:3 [ "entidad" => "Servicio de Dermatología, Hospital Clínic de Barcelona, IDIBAPS, Universitat de Barcelona, CIBER de Enfermedades Raras, Barcelona, Spain" "etiqueta" => "f" "identificador" => "aff0030" ] 6 => array:3 [ "entidad" => "Servicio de Dermatología, Instituto Valenciano de Oncología, Valencia, Spain" "etiqueta" => "g" "identificador" => "aff0035" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Revisión de los términos que definen un carcinoma epidermoide cutáneo asociado a mal pronóstico" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">Cutaneous squamous cell carcinoma (cSCC) is the second most common cancer and its incidence is underestimated and increasing.<a class="elsevierStyleCrossRefs" href="#bib0570"><span class="elsevierStyleSup">1,2</span></a> The number of cases of cSCC has increased between 50% and 300% over the last 30 years,<a class="elsevierStyleCrossRef" href="#bib0580"><span class="elsevierStyleSup">3</span></a> and in 2030 its incidence is projected to double in European countries.<a class="elsevierStyleCrossRef" href="#bib0585"><span class="elsevierStyleSup">4</span></a> Whether this increase is real or corresponds to early detection of the disease is subject of debate.<a class="elsevierStyleCrossRef" href="#bib0590"><span class="elsevierStyleSup">5</span></a> The increased incidence is, nevertheless still apparent in studies that exclude cases of in situ cSCC.<a class="elsevierStyleCrossRef" href="#bib0595"><span class="elsevierStyleSup">6</span></a> While recognizing that data on the cSCC incidence may be unreliable, it is estimated that the risk of developing cSCC at some point in an individual's life lies between 7% and 11% in the Caucasian population<a class="elsevierStyleCrossRef" href="#bib0600"><span class="elsevierStyleSup">7</span></a> (between 9% and 14% in men and 4% and 9% in women).<a class="elsevierStyleCrossRef" href="#bib0605"><span class="elsevierStyleSup">8</span></a> In Spain, studies that analyze raw incidence rates estimate values of 38.16 cases per 100 000 inhabitants per year,<a class="elsevierStyleCrossRef" href="#bib0610"><span class="elsevierStyleSup">9</span></a> although there are no registries that allow a true estimate. The incidence is somewhat greater than that reported in other European countries (see review by Lomas et al.<a class="elsevierStyleCrossRef" href="#bib0570"><span class="elsevierStyleSup">1</span></a>)</p><p id="par0010" class="elsevierStylePara elsevierViewall">Ten years after surgery for cSCC, survival is greater than 90%, the rate of lymph node metastasis is around 4%, and mortality is around 2%, although the tumor is an important public health problem responsible for a large number of deaths given its high incidence.<a class="elsevierStyleCrossRef" href="#bib0615"><span class="elsevierStyleSup">10</span></a> In fact, cSCC is the second most frequent cause of death due to skin cancer after melanoma and is responsible for most deaths due to skin cancer in indivduals aged over 85 years.<a class="elsevierStyleCrossRef" href="#bib0580"><span class="elsevierStyleSup">3</span></a> In some areas of the United States, mortality rates are comparable with renal carcinoma, oropharyngeal carcinoma, or melanoma.<a class="elsevierStyleCrossRef" href="#bib0580"><span class="elsevierStyleSup">3</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">In recent years, several authors have focused their research on analyzing factors associated with worse prognosis in cSCC. The literature refers to terms such as high-risk cSCC, locally advanced cSCC, metastatic SCC, advanced cSCC, and aggressive SCC. These terms can give rise to confusion and are not always well defined. This review aims to clarify these concepts and thus standardize description of this tumor, something we believe is necessary in light of new drugs already approved and those in clinical development.</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0030">Prognostic Factors in Cutaneous Squamous Cell Carcinoma</span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Clinical Prognostic Factors</span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Tumor-Related Factors</span><p id="par0020" class="elsevierStylePara elsevierViewall">The horizontal spread of the primary tumor is a well-known prognostic factors in cSCC.<a class="elsevierStyleCrossRefs" href="#bib0620"><span class="elsevierStyleSup">11–22</span></a> A diameter greater than 2<span class="elsevierStyleHsp" style=""></span>cm has been associated with a 3-fold greater risk of recurrence and 6-fold greater risk of metastasis.<a class="elsevierStyleCrossRef" href="#bib0675"><span class="elsevierStyleSup">22</span></a> The most specific cutoff for determining high risk associated with tumor size has been set at 4<span class="elsevierStyleHsp" style=""></span>cm.<a class="elsevierStyleCrossRef" href="#bib0680"><span class="elsevierStyleSup">23</span></a></p><p id="par0025" class="elsevierStylePara elsevierViewall">Certain sites are associated with worse prognosis in cSCC.<a class="elsevierStyleCrossRefs" href="#bib0580"><span class="elsevierStyleSup">3,11,13,15,16,19,24–30</span></a> Traditionally, the outer ear and lower lip have been considered sites of high risk, with a 2-fold increase in the risk of metastasis,<a class="elsevierStyleCrossRefs" href="#bib0625"><span class="elsevierStyleSup">12,15</span></a> and in one systematic review, the temples were associated with an even greater risk of recurrence and metastasis. The vermilion border of the lower lip is associated with a 5-fold greater incidence of lymph node metastases compared with involvement of the skin of the lip alone; cSCC located on the cutaneous part of the lip have lymph node involvement rates similar to those of other areas.<a class="elsevierStyleCrossRef" href="#bib0720"><span class="elsevierStyleSup">31</span></a> The risk of lymph node spread is not as high in the nose or internal canthus of the eye, although local progression is an important problem in these areas.</p><p id="par0030" class="elsevierStylePara elsevierViewall">Recurrence of the primary tumor has been associated with a greater risk of lymph node metastasis.<a class="elsevierStyleCrossRefs" href="#bib0625"><span class="elsevierStyleSup">12,13,24</span></a> In addition, recurrent cSCC appears to be more aggressive than primary cSCC and has been associated with a larger tumor size and greater risk of perineural and lymphovascular invasion, as well as invasion of subcutaneous cell tissue.<a class="elsevierStyleCrossRef" href="#bib0635"><span class="elsevierStyleSup">14</span></a> Presence of involved borders after the initial excision is also considered a risk factor (recurrence in 50% of cases).</p><p id="par0035" class="elsevierStylePara elsevierViewall">Clinical evidence suggests that rapid growth rate (GR) is an important risk factor for cSCC and this is reflected in the guidelines of the National Comprehensive Cancer Network.<a class="elsevierStyleCrossRef" href="#bib0725"><span class="elsevierStyleSup">32</span></a> An old study had already found an association between rapidly-growing tumors and worse prognosis.<a class="elsevierStyleCrossRef" href="#bib0730"><span class="elsevierStyleSup">33</span></a> More recently, it has been observed that GR<span class="elsevierStyleHsp" style=""></span>><span class="elsevierStyleHsp" style=""></span>4<span class="elsevierStyleHsp" style=""></span>mm/month in the long axis of the tumor is associated with worse disease prognosis and a greater risk of lymph node metastasis.<a class="elsevierStyleCrossRef" href="#bib0735"><span class="elsevierStyleSup">34</span></a></p><p id="par0040" class="elsevierStylePara elsevierViewall">Finally, the association of neurologic symptoms with cSCC is a clinical marker of poor prognosis that is usually associated with presence of perineural invasion (PNI) (see <span class="elsevierStyleItalic">Histopathologic Prognostic Factors</span> below). Symptoms associated with PNI in cSCC include above all pain and paresthesia, although itching, stinging, and, more rarely, motor nerve paralysis may be present.<a class="elsevierStyleCrossRefs" href="#bib0725"><span class="elsevierStyleSup">32,35</span></a> Moreover, pain seems to be a key symptom in the identification of cSCC in solid organ transplant recipients.<a class="elsevierStyleCrossRef" href="#bib0745"><span class="elsevierStyleSup">36</span></a></p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">Patient-Related Factors</span><p id="par0045" class="elsevierStylePara elsevierViewall">Immunosuppression is a risk factor for the development of cSCC. cSCC is particularly common in solid organ transplant recipients, most frequently affecting those who have undergone heart transplantation. This group of patients is followed by recipients of lung, kidney, and liver transplants<a class="elsevierStyleCrossRef" href="#bib0750"><span class="elsevierStyleSup">37</span></a>; those with hematological malignancies, particularly chronic lymphatic leukemia and small cell lymphocytic lymphoma<a class="elsevierStyleCrossRef" href="#bib0755"><span class="elsevierStyleSup">38</span></a>; those receiving chronic immunosuppressant treatment, particularly cyclosporin<a class="elsevierStyleCrossRef" href="#bib0760"><span class="elsevierStyleSup">39</span></a> and azathioprine<a class="elsevierStyleCrossRef" href="#bib0765"><span class="elsevierStyleSup">40</span></a>—especially after exposure to UV radiation<a class="elsevierStyleCrossRefs" href="#bib0765"><span class="elsevierStyleSup">40,41</span></a>; and those positive for HIV.<a class="elsevierStyleCrossRef" href="#bib0775"><span class="elsevierStyleSup">42</span></a> The cumulative incidence of cSCC increases progressively with duration of immunosuppression,<a class="elsevierStyleCrossRefs" href="#bib0780"><span class="elsevierStyleSup">43,44</span></a> and, in general the tumor is more aggressive in immunosuppressed patients.<a class="elsevierStyleCrossRefs" href="#bib0640"><span class="elsevierStyleSup">15,42,45–47</span></a></p><p id="par0050" class="elsevierStylePara elsevierViewall">Worse prognosis has been demonstrated in cSCC that develops on long-standing scars, particularly those caused by burns<a class="elsevierStyleCrossRefs" href="#bib0805"><span class="elsevierStyleSup">48,49</span></a> and on previously irradiated skin.<a class="elsevierStyleCrossRefs" href="#bib0815"><span class="elsevierStyleSup">50,51</span></a> cSCC is also more aggressive in some genodermatoses, particularly bullous epidermolysis, where it is the leading cause of death.<a class="elsevierStyleCrossRef" href="#bib0825"><span class="elsevierStyleSup">52</span></a> cSCC is more frequent in other hereditary diseases, such as xeroderma pigmentosum,<a class="elsevierStyleCrossRefs" href="#bib0830"><span class="elsevierStyleSup">53,54</span></a> oculocutaneous albinism,<a class="elsevierStyleCrossRefs" href="#bib0840"><span class="elsevierStyleSup">55,56</span></a> congenital dyskeratosis, Bloom syndrome,<a class="elsevierStyleCrossRef" href="#bib0850"><span class="elsevierStyleSup">57</span></a> Rothmund-Thomson syndrome,<a class="elsevierStyleCrossRefs" href="#bib0855"><span class="elsevierStyleSup">58,59</span></a> Werner syndrome,<a class="elsevierStyleCrossRef" href="#bib0865"><span class="elsevierStyleSup">60</span></a> keratitis, ichthyosis, and deafness syndrome,<a class="elsevierStyleCrossRefs" href="#bib0870"><span class="elsevierStyleSup">61,62</span></a> Ferguson-Smith syndrome,<a class="elsevierStyleCrossRefs" href="#bib0880"><span class="elsevierStyleSup">63,64</span></a> Muir-Torre syndrome,<a class="elsevierStyleCrossRef" href="#bib0890"><span class="elsevierStyleSup">65</span></a> and Lewandosky-Lutz syndrome,<a class="elsevierStyleCrossRef" href="#bib0895"><span class="elsevierStyleSup">66</span></a> among others. Although there is no information to support the affirmation that cSCC is more aggressive in all these diseases, and indeed in some of them the tumor tends to show a reasonably good prognosis, the high risk requires strict management protocols in these patients.<a class="elsevierStyleCrossRefs" href="#bib0900"><span class="elsevierStyleSup">67,68</span></a></p></span></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Histopathological Prognostic Factors</span><p id="par0055" class="elsevierStylePara elsevierViewall">Thickness has been related to prognosis of cSCC in several studies,<a class="elsevierStyleCrossRefs" href="#bib0620"><span class="elsevierStyleSup">11,12,14–17,21,22,25,69–72</span></a> and it has even been identified as the most important predictive factor for metastasis.<a class="elsevierStyleCrossRef" href="#bib0645"><span class="elsevierStyleSup">16</span></a> The probability of metastasis is almost nonexistent if the thickness of the tumor is less than 2<span class="elsevierStyleHsp" style=""></span>mm, approximately 6% in tumors of 2 to 6<span class="elsevierStyleHsp" style=""></span>mm, and 16% in those more than 6<span class="elsevierStyleHsp" style=""></span>mm thick.<a class="elsevierStyleCrossRef" href="#bib0645"><span class="elsevierStyleSup">16</span></a> Thickness should be measured from the stratum granulosum of normal skin adjacent to the tumor to the last invasive cell.<a class="elsevierStyleCrossRef" href="#bib0680"><span class="elsevierStyleSup">23</span></a> This approach may be difficult when measuring thickness of exophytic lesions.</p><p id="par0060" class="elsevierStylePara elsevierViewall">Tumor invasion beyond subcutaneous fat is another prognostic factor that has received attention in recent years.<a class="elsevierStyleCrossRefs" href="#bib0615"><span class="elsevierStyleSup">10,17,18</span></a> Presence of such invasion has been associated with a 7-fold greater risk of recurrence and an 11-fold greater risk of metastasis.<a class="elsevierStyleCrossRef" href="#bib0675"><span class="elsevierStyleSup">22</span></a> Assessment of invasion beyond fatty tissue may, however, be more useful compared with tumor depth in some aspects. On one hand, it is useful in Mohs micrographic surgery, which assesses horizontal cuts in the surgical piece, in which the tumor thickness in millimeters cannot be assessed. In addition, the difficulties associated with assessing tumor depth in exophytic lesions are obviated and, furthermore, this assessment can justify the poor prognosis in some lesions that invade muscle despite having a moderate thickness.</p><p id="par0065" class="elsevierStylePara elsevierViewall">Poor differentiation has been associated with poor prognosis of cSCC in several studies.<a class="elsevierStyleCrossRefs" href="#bib0620"><span class="elsevierStyleSup">11,16,17,19–22,25–27,69–79</span></a> According to published series, between 8%<a class="elsevierStyleCrossRef" href="#bib0945"><span class="elsevierStyleSup">76</span></a> and 25%<a class="elsevierStyleCrossRef" href="#bib0645"><span class="elsevierStyleSup">16</span></a> of cSCC are poorly differentiated. Differentiation has been associated with a 3-fold greater risk of local recurrence and a 5-fold greater risk of metastasis,<a class="elsevierStyleCrossRef" href="#bib0675"><span class="elsevierStyleSup">22</span></a> as well as earlier recurrence.</p><p id="par0070" class="elsevierStylePara elsevierViewall">PNI is present in 2.5% to 10% of cSCC and is associated with other histopathological features of poor prognosis.<a class="elsevierStyleCrossRef" href="#bib0635"><span class="elsevierStyleSup">14</span></a> Studies have consistently recognized its implication in poor prognosis and it has been associated with a 4-fold greater risk of recurrence and a 5-fold greater risk of metastasis.<a class="elsevierStyleCrossRef" href="#bib0675"><span class="elsevierStyleSup">22</span></a> More recently, it has been established that PNI should be considered as high risk when nerves with a caliber ≥0.1<span class="elsevierStyleHsp" style=""></span>mm are involved.<a class="elsevierStyleCrossRefs" href="#bib0615"><span class="elsevierStyleSup">10,17,18</span></a> Moreover, PNI of deep nerves (located below the dermis) and extensive PNI are considered PNI features also associated with poor prognosis.<a class="elsevierStyleCrossRef" href="#bib0965"><span class="elsevierStyleSup">80</span></a> It is necessary to differentiate between PNI and perineural dissemination. The former corresponds to histological detection whereas the second, by definition, is a more advanced stage that can be detected clinically and radiologically and is the pathway for invasion of the central nervous system by the tumor.<a class="elsevierStyleCrossRef" href="#bib0970"><span class="elsevierStyleSup">81</span></a></p><p id="par0075" class="elsevierStylePara elsevierViewall">Other histopathological risk factors in cSCC are lymphovascular invasion,<a class="elsevierStyleCrossRef" href="#bib0690"><span class="elsevierStyleSup">25</span></a> infiltrative growth pattern,<a class="elsevierStyleCrossRef" href="#bib0975"><span class="elsevierStyleSup">82</span></a> desmoplasia,<a class="elsevierStyleCrossRefs" href="#bib0645"><span class="elsevierStyleSup">16,83,84</span></a> defined as least 30% of the desmoplastic stroma associated with the tumor, and budding,<a class="elsevierStyleCrossRefs" href="#bib0990"><span class="elsevierStyleSup">85,86</span></a> defined by the presence of nests of 4–5 cells at the invasive front, although a clear consensus is lacking on this point.<a class="elsevierStyleCrossRef" href="#bib1000"><span class="elsevierStyleSup">87</span></a> In addition, worse prognosis has been associated with certain histopathological variants of cSCC, particularly acantholytic cSCC,<a class="elsevierStyleCrossRefs" href="#bib1005"><span class="elsevierStyleSup">88,89</span></a> and adenosquamous cSCC,<a class="elsevierStyleCrossRef" href="#bib1015"><span class="elsevierStyleSup">90</span></a> although recent series seem to suggest that the prognostic relevance of these features could be limited.<a class="elsevierStyleCrossRef" href="#bib1020"><span class="elsevierStyleSup">91</span></a> The presence of an eosinophil-rich infiltrate and plasma cells has also been assessed,<a class="elsevierStyleCrossRef" href="#bib0695"><span class="elsevierStyleSup">26</span></a> but more studies are needed to characterize inflammatory infiltrate associated with cSCC and relate the findings more reliably to prognosis. Some markers, such as EGFR,<a class="elsevierStyleCrossRefs" href="#bib1025"><span class="elsevierStyleSup">92,93</span></a> D2-40,<a class="elsevierStyleCrossRefs" href="#bib1035"><span class="elsevierStyleSup">94,95</span></a> and epithelial to mesenchymal transition markers<a class="elsevierStyleCrossRef" href="#bib1045"><span class="elsevierStyleSup">96</span></a> have been associated with unfavorable prognosis in cSCC. Recently, expression of PD-L1<a class="elsevierStyleCrossRefs" href="#bib1050"><span class="elsevierStyleSup">97–99</span></a> has been linked to a higher risk of lymph node metastases.</p><p id="par0080" class="elsevierStylePara elsevierViewall">The staging systems use a combination of risk factors to define the different risk groups in. For cSCC, the 8th edition of the American Joint Committee on Cancer (AJCC) staging system and the alternative system of the Brigham and Women's Hospital are used. The characteristics of these systems are shown in <a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>.</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia></span></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0055">Terms Used to Describe Cutaneous Squamous Cell Carcinoma With Poor Prognosis</span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0060">High-Risk Cutaneous Squamous Cell Carcinoma</span><p id="par0085" class="elsevierStylePara elsevierViewall">In practical terms, the presence of one of the factors of poor prognosis is what defines a cSCC as being of high risk (<a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>). However, the prognostic relevance of each factor is not the same and the combination of several is known to confer a greater risk than the presence of each by itself.<a class="elsevierStyleCrossRefs" href="#bib0655"><span class="elsevierStyleSup">18,100–102</span></a> Thus, a better definition of high-risk cSCC would require a better understanding of the prognostic relevance of each of the risk factors on one hand and their combination on the other. According to the current staging system<a class="elsevierStyleCrossRef" href="#bib0680"><span class="elsevierStyleSup">23</span></a> and the alternative BWH system,<a class="elsevierStyleCrossRef" href="#bib1065"><span class="elsevierStyleSup">100</span></a> high-risk cSCC would be considered as T3/T4 tumors as per the AJJCC-8 system or T2b/T3 as per the alternative BWH staging system. However, many tumors staged according to these systems are not going to be particularly aggressive.</p><elsevierMultimedia ident="tbl0010"></elsevierMultimedia></span><span id="sec0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0065">Locally Advanced cSCC</span><p id="par0090" class="elsevierStylePara elsevierViewall">There is no standard definition of locally advanced cSCC, although all definitions do have points in common. These tumors have been defined as those not potentially curable or that are unlikely to be cured with surgery, radiotherapy, or combination treatment (surgery and radiotherapy) after consultation in a multidisciplinary committee.<a class="elsevierStyleCrossRef" href="#bib1080"><span class="elsevierStyleSup">103</span></a> This definition is routed in clinical practice and has also been taken as a reference in some clinical trials in other types of nonmelanoma skin cancer, specifically basal cell carcinoma.<a class="elsevierStyleCrossRef" href="#bib1085"><span class="elsevierStyleSup">104</span></a></p><p id="par0095" class="elsevierStylePara elsevierViewall">The criteria for considering cSCC as locally advanced in a trial of the anti-PD1 drug recently approved for cSCC was that patients were not candidates for surgery for the following reasons: recurrence after 2 or more surgical procedures and curative resection was considered unlikely or because surgical treatment would lead to substantial complications or deformity.<a class="elsevierStyleCrossRef" href="#bib1090"><span class="elsevierStyleSup">105</span></a> It is more difficult in theory to define which patients with cSCC cannot be considered candidates for conventional treatment. Those cases with extensive bone involvement, in view of the availability of new drugs, could be considered to benefit. <a class="elsevierStyleCrossRef" href="#tbl0015">Table 3</a> shows some clinical scenarios that would allow classification of cSCC as locally advanced.</p><elsevierMultimedia ident="tbl0015"></elsevierMultimedia></span><span id="sec0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0070">Metastatic cSCC</span><p id="par0100" class="elsevierStylePara elsevierViewall">Metastatic cSCC is defined as cSCC that has spread from its primary site in the skin. In most cases, metastasis is to lymph nodes or the parotid gland, and to a lesser extent to other organs. In transit involvement in the skin in cSCC, defined as a presence of foci of tumors differentiated from the primary tumor and before the first draining lymph node,<a class="elsevierStyleCrossRef" href="#bib1095"><span class="elsevierStyleSup">106</span></a> could be considered a form of locoregional metastatic cSCC, by analogy with melanoma, although no change to the N category occurs in staging of the cSCC.<a class="elsevierStyleCrossRef" href="#bib1100"><span class="elsevierStyleSup">107</span></a></p><p id="par0105" class="elsevierStylePara elsevierViewall">Approximately 5% of cSCC are thought to progress to metastasis,<a class="elsevierStyleCrossRef" href="#bib1105"><span class="elsevierStyleSup">108</span></a> although to date no exhaustive registers have been available to derive a true estimate. In 2013, in England, the automated registries included cSCC and metastatic cSCC, thereby enabling study of data at the population level for the first time.<a class="elsevierStyleCrossRef" href="#bib1110"><span class="elsevierStyleSup">109</span></a> During 15.5 months of follow-up, 2.1% of the patients with cSCC developed metastatic disease,<a class="elsevierStyleCrossRef" href="#bib1110"><span class="elsevierStyleSup">109</span></a> although the authors considered that the rate could be an underestimate given that International Classification of Diseases, 10th version, did not include specific codes for metastatic cSCC. Of these metastatic cSCC, metastasis occurred within 3 years of diagnosis of the primary tumor in 90% of cases.<a class="elsevierStyleCrossRef" href="#bib1110"><span class="elsevierStyleSup">109</span></a></p></span><span id="sec0055" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0075">Advanced cSCC and Aggressive cSCC</span><p id="par0110" class="elsevierStylePara elsevierViewall">In practice, the terms advanced cSCC and aggressive cSCC have been used to refer to more general clinical situations. Thus, the term advanced cSCC has been used to group locally advanced cSCC and metastatic cSCC.<a class="elsevierStyleCrossRef" href="#bib1090"><span class="elsevierStyleSup">105</span></a> The term aggressive cSCC, in contrast, has been used to refer to metastatic cSCC and cSCC that leads to death due to local progression.<a class="elsevierStyleCrossRef" href="#bib0790"><span class="elsevierStyleSup">45</span></a> The terms advanced and aggressive, however, may be nonspecific and, therefore, when they are used, it is appropriate to define the clinical context to which they refer. The following terms are related to poor prognosis in cSCC: aggressive cSCC, locally advanced cSCC, metastatic cSCC, advanced cSCC, and aggressive cSCC (<a class="elsevierStyleCrossRef" href="#tbl0020">Table 4</a>).</p><elsevierMultimedia ident="tbl0020"></elsevierMultimedia></span></span><span id="sec0060" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0080">Basic Principles for Management of High-Risk, Locally Advanced, and Metastatic Cutaneous Squamous Cell Carcinoma</span><p id="par0115" class="elsevierStylePara elsevierViewall">Conventional surgery is the treatment of choice for most cases of cSCC, with differences in the margin depending on whether the tumor is low-risk cSCC (4<span class="elsevierStyleHsp" style=""></span>mm) or aggressive cSCC (10<span class="elsevierStyleHsp" style=""></span>mm).<a class="elsevierStyleCrossRef" href="#bib1115"><span class="elsevierStyleSup">110</span></a> Mohs surgery is reserved for recurrent cases and for high-risk sites in which the safety margins might lead to significant functional compromise or unacceptable cosmetic outcomes. Adjuvant radiotherapy of the primary tumor is reserved for cases with PNI, particularly clinical, radiographic, extensive, involvement of nerves with caliber 0.1<span class="elsevierStyleHsp" style=""></span>mm or more, of deep nerves, and for cases with positive margins that cannot be operated again safely to leave the patient tumor free.<a class="elsevierStyleCrossRef" href="#bib0965"><span class="elsevierStyleSup">80</span></a> In inoperable patients, elective radiotherapy and both destructive and intralesional treatment can be an option.<a class="elsevierStyleCrossRefs" href="#bib0725"><span class="elsevierStyleSup">32,110</span></a> The usefulness of selective lymph node biopsy has yet to be established, although it might be beneficial in certain patient groups.<a class="elsevierStyleCrossRef" href="#bib1120"><span class="elsevierStyleSup">111</span></a></p><p id="par0120" class="elsevierStylePara elsevierViewall">Management of locally advanced cSCC is complex. In general, surgery by itself is insufficient or is inappropriate given the cosmetic and functional repercussions. New anti-PD1 drugs are now available and cemiplimab has been approved for the treatment of locally advanced cSCC<a class="elsevierStyleCrossRef" href="#bib1090"><span class="elsevierStyleSup">105</span></a>; this drug may be considered the option of choice provided the patient has an acceptable performance status at baseline. If the systemic option is not possible given the circumstances of the patient, palliative treatment can be considered. It is not clear whether systemic treatment is beneficial for reducing tumor mass and enabling surgical treatment with fewer sequelae for the patient (neoadjuvant setting).</p><p id="par0125" class="elsevierStylePara elsevierViewall">In the case of metastatic cSCC, surgery is recommended whenever possible, followed by complementary radiotherapy.<a class="elsevierStyleCrossRefs" href="#bib0965"><span class="elsevierStyleSup">80,112,113</span></a> In inoperable cases, if the patient has a good performance status, systemic treatment, currently with anti-PD1 agents, is the preferred option. Despite the age of the affected population, a significant proportion of patients with advanced cSCC have a clinical situation that allows systemic treatment.<a class="elsevierStyleCrossRef" href="#bib1080"><span class="elsevierStyleSup">103</span></a> Cemiplimab is the only agent approved for the treatment of metastatic cSCC and locally advanced cSCC.<a class="elsevierStyleCrossRef" href="#bib1090"><span class="elsevierStyleSup">105</span></a> In patients with inadequate performance status and inoperable patients who are not candidates for or who do not respond to systemic treatment, palliative treatment is an option to be considered. Given that management of metastatic cSCC and locally advanced cSCC is fairly similar, the term advanced cSCC can be used to refer to those clinical scenarios.</p></span><span id="sec0065" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0085">Conclusion</span><p id="par0130" class="elsevierStylePara elsevierViewall">Currently, there is no consensus definition for locally advanced cSCC and, given the imminent arrival of new drugs, such a consensus would seem necessary. The working group has concluded that locally advanced cSCC could be considered a tumor that cannot be cured with conventional treatments (surgery, radiotherapy, or a combination of both) after consultation in a multidisciplinary committee or cSCC in which surgery would involve functional sequelae or unacceptable cosmetic outcomes. Metastatic cSCC is defined as cSCC that has spread from its primary site in the skin. Advanced cSCC includes cases of locally advanced cSCC and metastatic cSCC, while cases of metastatic cSCC and locally advanced cSCC that cause death due to local progression (which could be considered cSCC that gives rise to major events) can both be termed aggressive cSCC. High risk cSCC is cSCC that has high-risk clinical or histopathological features, although this definition may be too broad given that it groups tumors that probably would not lead to unfavorable outcomes, and so better staging of these tumors will be needed in the future.</p></span><span id="sec0070" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0090">Funding</span><p id="par0135" class="elsevierStylePara elsevierViewall">J.C. was partially funded for the projects: PI18/000587 (Instituto de Salud Carlos III, cofunded by <span class="elsevierStyleGrantSponsor" id="gs1">FEDER</span> grants) and GRS 1835/A/18 (<span class="elsevierStyleGrantSponsor" id="gs2">Regional Health Service of Castille and Leon</span>).</p></span><span id="sec0075" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0095">Conflicts of Interest</span><p id="par0140" class="elsevierStylePara elsevierViewall">The authors have received honoraria as members of an Advisory Board for Sanofi.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:12 [ 0 => array:3 [ "identificador" => "xres1344880" "titulo" => "Abstract" "secciones" => array:1 [ 0 => array:1 [ "identificador" => "abst0005" ] ] ] 1 => array:2 [ "identificador" => "xpalclavsec1237561" "titulo" => "Keywords" ] 2 => array:3 [ "identificador" => "xres1344879" "titulo" => "Resumen" "secciones" => array:1 [ 0 => array:1 [ "identificador" => "abst0010" ] ] ] 3 => array:2 [ "identificador" => "xpalclavsec1237562" "titulo" => "Palabras clave" ] 4 => array:2 [ "identificador" => "sec0005" "titulo" => "Introduction" ] 5 => array:3 [ "identificador" => "sec0010" "titulo" => "Prognostic Factors in Cutaneous Squamous Cell Carcinoma" "secciones" => array:2 [ 0 => array:3 [ "identificador" => "sec0015" "titulo" => "Clinical Prognostic Factors" "secciones" => array:2 [ 0 => array:2 [ "identificador" => "sec0020" "titulo" => "Tumor-Related Factors" ] 1 => array:2 [ "identificador" => "sec0025" "titulo" => "Patient-Related Factors" ] ] ] 1 => array:2 [ "identificador" => "sec0030" "titulo" => "Histopathological Prognostic Factors" ] ] ] 6 => array:3 [ "identificador" => "sec0035" "titulo" => "Terms Used to Describe Cutaneous Squamous Cell Carcinoma With Poor Prognosis" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "sec0040" "titulo" => "High-Risk Cutaneous Squamous Cell Carcinoma" ] 1 => array:2 [ "identificador" => "sec0045" "titulo" => "Locally Advanced cSCC" ] 2 => array:2 [ "identificador" => "sec0050" "titulo" => "Metastatic cSCC" ] 3 => array:2 [ "identificador" => "sec0055" "titulo" => "Advanced cSCC and Aggressive cSCC" ] ] ] 7 => array:2 [ "identificador" => "sec0060" "titulo" => "Basic Principles for Management of High-Risk, Locally Advanced, and Metastatic Cutaneous Squamous Cell Carcinoma" ] 8 => array:2 [ "identificador" => "sec0065" "titulo" => "Conclusion" ] 9 => array:2 [ "identificador" => "sec0070" "titulo" => "Funding" ] 10 => array:2 [ "identificador" => "sec0075" "titulo" => "Conflicts of Interest" ] 11 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2019-03-13" "fechaAceptado" => "2019-06-02" "PalabrasClave" => array:2 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec1237561" "palabras" => array:3 [ 0 => "Cutaneous squamous cell carcinoma" 1 => "High-risk cutaneous squamous cell carcinoma" 2 => "Staging" ] ] ] "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec1237562" "palabras" => array:3 [ 0 => "Carcinoma escamoso cutáneo" 1 => "Carcinoma epidermoide cutáneo" 2 => "Carcinoma epidermoide cutáneo de alto riesgo estadificación" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:2 [ "titulo" => "Abstract" "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Cutaneous squamous cell carcinoma (cSCC) is the second most common cancer in humans and its incidence is both underestimated and on the rise. cSCC is referred to in the literature as high-risk cSCC, locally advanced cSCC, metastatic cSCC, advanced cSCC, and aggressive cSCC. These terms can give rise to confusion and are not always well defined. In this review, we aim to clarify the concepts underlying these terms with a view to standardizing the description of this tumor, something we believe is necessary in light of the new drugs that have been approved or are in development for cSCC.</p></span>" ] "es" => array:2 [ "titulo" => "Resumen" "resumen" => "<span id="abst0010" class="elsevierStyleSection elsevierViewall"><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">El carcinoma epidermoide cutáneo (CEC) es el segundo tumor más frecuente en humanos y tiene una incidencia creciente e infraestimada. En la literatura nos encontramos con términos como CEC de alto riesgo, CEC localmente avanzado, CEC metastásico, CEC avanzado y CEC agresivo, que pueden dar lugar a confusión y que en algunas ocasiones no se encuentran del todo bien definidos. En esta revisión pretendemos aclarar estos conceptos con la idea de lograr homogeneidad en su descripción, algo que parece necesario a la luz de los nuevos fármacos aprobados y en desarrollo para este tumor.</p></span>" ] ] "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0010">Please cite this article as: Cañueto J, Tejera-Vaquerizo A, Redondo P, Botella-Estrada R, Puig S, Sanmartin O. Revisión de los términos que definen un carcinoma epidermoide cutáneo asociado a mal pronóstico. Actas Dermosifiliogr. 2020;111:281–290.</p>" ] ] "multimedia" => array:4 [ 0 => array:8 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at1" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:3 [ "leyenda" => "<p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">A) AJCC 8th Edition: includes site on lower lip; excludes eyelid carcinoma. Tumors of the vulva, penis, perineal region, and other sites other than the head and neck are excluded. ENE (extranodal or extracapsular extension) defined as extension through the lymph node capsule into adjacent connective tissue, with or without stromal response. B) Brigham and Women's Hospital Alternative Staging System.</p>" "tablatextoimagen" => array:2 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " colspan="4" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">A) American Joint Committee on Cancer (AJCC) 8th Edition</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">T \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">TX \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Primary tumor cannot be assessed (after curettage...) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">T0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">No evidence of primary tumor \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Tis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">In situ carcinoma \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">T1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Up to 2<span class="elsevierStyleHsp" style=""></span>cm in greatest diameter \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">T2 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Tumor ≥2<span class="elsevierStyleHsp" style=""></span>cm but <4<span class="elsevierStyleHsp" style=""></span>cm in greatest diameter \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">T3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Tumor ≥4<span class="elsevierStyleHsp" style=""></span>cm in greatest diameter or minor bone invasion or perineural invasion or deep invasion<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">T4 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Tumor with gross cortical bone and/or marrow invasion (T4a), tumor with skull bone invasion and/or skull base foramen involvement (T4b) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">N \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">NX \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Lymph node involvement cannot be assessed (prior resection for another reason, body habitus...) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">N0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">No involvement of lymph nodes as determined clinically/radiologically \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">N1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Metastasis in an isolated ipsilateral lymph node ≤ 3<span class="elsevierStyleHsp" style=""></span>cm in greatest diameter, ENE (–) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">N2 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">N2a: Metastasis in an isolated ipsilateral lymph node 3–6<span class="elsevierStyleHsp" style=""></span>cm in greatest diameter, ENE (–) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">N2b: Metastasis in multiple ipsilateral lymph nodes less than 6<span class="elsevierStyleHsp" style=""></span>cm, ENE (–) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">N2c: Metastasis in bilateral or contralateral lymph nodes, less than 6<span class="elsevierStyleHsp" style=""></span>cm, ENE (–) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">N3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">N3a: Metastasis in a lymph node greater than 6<span class="elsevierStyleHsp" style=""></span>cm, ENE (–) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">N3b: Metastasis in any lymph node(s) and ENE (+) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">M \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">M0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Absence of distant metastasis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">M1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Distant metastasis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="4" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">AJCC TNM Staging System for cSCC of Head and Neck (Eighth Edition)</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">T1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">N0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">M0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Stage I \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">T2 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">N0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">M0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Stage II \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">T3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">N0, N1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">M0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Stage III \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">T1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">N1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">M0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Stage III \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">T2 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">N1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">M0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Stage III \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">T1–T3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">N2 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">M0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Stage IV \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Any T \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">N3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">M0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Stage IV \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">T4 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Any N \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">M0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Stage IV \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Any T \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Any N \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">M1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Stage IV \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab2307213.png" ] ] 1 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " colspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">B) Brigham and Women's Hospital Alternative Staging System</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">T1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0 high-risk factors \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">T2a \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1 high-risk factor \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">T2b \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2–3 high-risk factors \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">T3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">4 or more high-risk factors/bone invasion \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">High-risk factors for BWH staging system \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Diameter of 2<span class="elsevierStyleHsp" style=""></span>cm or more \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Poor degree of differentiation \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Perineural invasion of nerves ≥0.1<span class="elsevierStyleHsp" style=""></span>mm in caliber \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Tumor invasion beyond subcutaneous fat (excluding bone invasion, which upgrades tumor to BWH stage T3) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab2307214.png" ] ] ] "notaPie" => array:1 [ 0 => array:3 [ "identificador" => "tblfn0005" "etiqueta" => "a" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Deep invasion defined as thickness greater than 6<span class="elsevierStyleHsp" style=""></span>mm or invasion beyond subcutaneous fat. For a tumor to be T3, perineural invasion should be in nerves greater than 0.1<span class="elsevierStyleHsp" style=""></span>mm in caliber, nerves beyond the dermis, or clinical and radiological involvement of nerves should be present without involvement or invasion of the base of the cranium.</p>" ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Staging of Cutaneous Squamous Cell Carcinoma.</p>" ] ] 1 => array:8 [ "identificador" => "tbl0010" "etiqueta" => "Table 2" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at2" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Low Risk \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">High Risk \t\t\t\t\t\t\n \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="3" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">Clinical Features</span></td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Size \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><20<span class="elsevierStyleHsp" style=""></span>mm \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><20<span class="elsevierStyleHsp" style=""></span>mm \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Site \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Outside the H/zone \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Ear, lower lip, temple \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Primary/recurrent \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Primary \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Recurrent \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Borders \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Well-defined \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Poorly-defined \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Immune status \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Immunocompetent \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Immunosuppressed \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Growth rate \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Slow \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Rapid \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Associated clinical features \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Asymptomatic \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Pain, paresthesia \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="3" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="3" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">Histopathological features</span></td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Thickness \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><6<span class="elsevierStyleHsp" style=""></span>mm \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">>6<span class="elsevierStyleHsp" style=""></span>mm \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Depth of invasion \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Dermis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Beyond fatty tissue \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Degree of differentiation \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Good-moderate \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Poor \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Perineural invasion \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">No \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Yes (nerves 0.1<span class="elsevierStyleHsp" style=""></span>mm or more, deep) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Histologic subtype \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Verrucous, keratoacanthoma \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Desmoplastic, adenosquamous \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab2307211.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Prognostic Factors in Cutaneous Squamous Cell Carcinoma (cSCC): Low-Risk and High-Risk cSCC.</p>" ] ] 2 => array:8 [ "identificador" => "tbl0015" "etiqueta" => "Table 3" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at3" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Tumor that invades bone structures \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Tumor with clinical or radiologic perineural invasion \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Tumor that is too big for curative surgery or if surgery is only possible with unacceptable cosmetic or functional outcomes \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Tumor that invades the entire tip of the nose or tumor that requires rhinectomy for excision \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Tumor that invades body cavities (cranial, thoracic, or abdominopelvic) or that has a high-risk of invading them \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Tumor that involves the ear and requires auriculectomy \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Tumor of the head and neck with direct extension to paranasal sinuses \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Tumor with in-transit metastasis \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Deep recurrence in an area with previous excision of the overlying cSCC \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Tumor that involves the eyelid or internal canthus and threatens orbital invasion \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab2307212.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Clinical Scenarios That Allow Classification of Cutaneous Squamous Cell Carcinoma as Locally Advanced.</p>" ] ] 3 => array:8 [ "identificador" => "tbl0020" "etiqueta" => "Table 4" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at4" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " colspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Definitions of cSCC in Clinical Practice</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">High-risk cSCC \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">cSCC that has at least 1 of the high-risk factors \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Locally advanced cSCC \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">cSCC that cannot be cured with conventional treatments (surgery, radiotherapy, or a combination of both) after consultation in a multidisciplinary committeecSCC in which surgery would result in unacceptable functional or cosmetic sequelae \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Metastatic cSCC \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">cSCC that has spread from its primary site in the skin \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Advanced cSCC \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Locally advanced or metastatic cSCC \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Aggressive cSCC \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Locally advanced cSCC or metastatic cSCC that causes death due to local progression \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab2307210.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">Definitions of Cutaneous Squamous Cell Carcinoma (cSCC) With Poor Prognosis in Clinical Practice.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:113 [ 0 => array:3 [ "identificador" => "bib0570" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A systematic review of worldwide incidence of nonmelanoma skin cancer" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1365-2133.2012.10830.x" "Revista" => array:6 [ "tituloSerie" => "Br J Dermatol" "fecha" => "2012" "volumen" => "166" "paginaInicial" => "1069" "paginaFinal" => "1080" "link" => array:1 [ …1] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0575" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "No end in sight: the skin cancer epidemic continues" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.sder.2011.01.002" "Revista" => array:6 [ "tituloSerie" => "Semin Cutan Med Surg" "fecha" => "2011" "volumen" => "30" "paginaInicial" => "3" "paginaFinal" => "5" "link" => array:1 [ …1] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0580" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The incidence and risk factors of metástasis for cutaneous squamous cell carcinoma—implications on the T-classification system" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/jso.23731" "Revista" => array:6 [ "tituloSerie" => "J Surg Oncol" "fecha" => "2014" "volumen" => "110" "paginaInicial" => "876" "paginaFinal" => "882" "link" => array:1 [ …1] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0585" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Incidence mortality, and trends of nonmelanoma skin cancer in Germany" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jid.2017.04.020" "Revista" => array:6 [ "tituloSerie" => "J Invest Dermatol" "fecha" => "2017" "volumen" => "137" "paginaInicial" => "1860" "paginaFinal" => "1867" "link" => array:1 [ …1] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0590" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Non-melanoma skin cancer incidence and impact of skin cancer screening on incidence" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/jid.2013.304" "Revista" => array:6 [ "tituloSerie" => "J Invest Dermatol" "fecha" => "2014" "volumen" => "134" "paginaInicial" => "43" "paginaFinal" => "50" "link" => array:1 [ …1] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0595" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cutaneous squamous cell carcinoma: estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jaad.2012.11.037" "Revista" => array:6 [ "tituloSerie" => "J Am Acad Dermatol" "fecha" => "2013" "volumen" => "68" "paginaInicial" => "957" "paginaFinal" => "966" "link" => array:1 [ …1] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0600" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Nonmelanoma skin cancer in the United States: incidence" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/s0190-9622(08)81509-5" "Revista" => array:8 [ "tituloSerie" => "J Am Acad Dermatol" "fecha" => "1994" "volumen" => "30" "numero" => "5 Pt 1" "paginaInicial" => "774" "paginaFinal" => "778" "link" => array:1 [ …1] "itemHostRev" => array:3 [ …3] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0605" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cutaneous squamous-cell carcinoma" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJM200103293441306" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2001" "volumen" => "344" "paginaInicial" => "975" "paginaFinal" => "983" "link" => array:1 [ …1] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0610" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Skin Cancer incidence and mortality in Spain: a systematic review and meta-analysis" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ad.2015.12.008" "Revista" => array:6 [ "tituloSerie" => "Actas Dermosifiliogr" "fecha" => "2016" "volumen" => "107" "paginaInicial" => "318" "paginaFinal" => "328" "link" => array:1 [ …1] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0615" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: a 10-year, single-institution cohort study" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/jamadermatol.2013.2139" "Revista" => array:6 [ "tituloSerie" => "JAMA Dermatol" "fecha" => "2013" "volumen" => "149" "paginaInicial" => "541" "paginaFinal" => "547" "link" => array:1 [ …1] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0620" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Microstaging of squamous cell carcinomas" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/ajcp/94.5.624" "Revista" => array:6 [ "tituloSerie" => "Am J Clin Pathol" "fecha" => "1990" "volumen" => "94" "paginaInicial" => "624" "paginaFinal" => "627" "link" => array:1 [ …1] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0625" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prognostic factors for local recurrence, metástasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/0190-9622(92)70144-5" "Revista" => array:6 [ "tituloSerie" => "J Am Acad Dermatol" "fecha" => "1992" "volumen" => "26" "paginaInicial" => "976" "paginaFinal" => "990" "link" => array:1 [ …1] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0630" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prognostic factors for metástasis in squamous cell carcinoma of the skin" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1046/j.1524-4725.2002.01169.x" "Revista" => array:7 [ "tituloSerie" => "Dermatol Surg" "fecha" => "2002" "volumen" => "28" "paginaInicial" => "268" "paginaFinal" => "273" "link" => array:1 [ …1] "itemHostRev" => array:3 [ …3] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0635" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Mortality risk from squamous cell skin cancer" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1200/JCO.2005.02.155" "Revista" => array:6 [ "tituloSerie" => "J Clin Oncol" "fecha" => "2005" "volumen" => "23" "paginaInicial" => "759" "paginaFinal" => "765" "link" => array:1 [ …1] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0640" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "High-risk cutaneous squamous cell carcinoma of the head and neck: results from 266 treated patients with metastatic lymph node disease" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/cncr.21898" "Revista" => array:6 [ "tituloSerie" => "Cancer" "fecha" => "2006" "volumen" => "106" "paginaInicial" => "2389" "paginaFinal" => "2396" "link" => array:1 [ …1] ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0645" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1200/JCO.1991.9.5.713" "Revista" => array:6 [ "tituloSerie" => "J Clin Oncol" "fecha" => "2008" "volumen" => "9" "paginaInicial" => "713" "paginaFinal" => "720" "link" => array:1 [ …1] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib0650" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Evaluation of American Joint Committee on Cancer, International Union Against Cancer, and Brigham and Women's Hospital tumor staging for cutaneous squamous cell carcinoma" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1200/JCO.2012.48.5326" "Revista" => array:6 [ "tituloSerie" => "J Clin Oncol" "fecha" => "2013" "volumen" => "32" "paginaInicial" => "327" "paginaFinal" => "334" "link" => array:1 [ …1] ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib0655" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system\" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/jamadermatol.2013.2456" "Revista" => array:6 [ "tituloSerie" => "JAMA Dermatol" "fecha" => "2013" "volumen" => "149" "paginaInicial" => "402" "paginaFinal" => "410" "link" => array:1 [ …1] ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib0660" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Sentinel lymph node biopsy and risk factors for predicting metastasis in cutaneous squamous cell carcinoma" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/bjd.13508" "Revista" => array:6 [ "tituloSerie" => "Br J Dermatol" "fecha" => "2015" "volumen" => "172" "paginaInicial" => "1029" "paginaFinal" => "1036" "link" => array:1 [ …1] ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib0665" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Risk factors related to locorregional recurrence in squamous cell carcinoma of the skin" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/(SICI)1096-9098(199602)61:2<124::AID-JSO6>3.0.CO;2-E" "Revista" => array:6 [ "tituloSerie" => "J Surg Oncol" "fecha" => "1996" "volumen" => "61" "paginaInicial" => "124" "paginaFinal" => "130" "link" => array:1 [ …1] ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib0670" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prediction score for lymph node metástasis from cutaneous squamous cell carcinoma of the external ear" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ejso.2014.07.039" "Revista" => array:6 [ "tituloSerie" => "Eur J Surg Oncol" "fecha" => "2015" "volumen" => "41" "paginaInicial" => "128" "paginaFinal" => "135" "link" => array:1 [ …1] ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib0675" "etiqueta" => "22" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Risk factors for cutaneous squamous cell carcinoma recurrence metastasis, and disease-specific death: a systematic review and meta-analysis" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/jamadermatol.2015.4994" "Revista" => array:6 [ "tituloSerie" => "JAMA Dermatol" "fecha" => "2016" "volumen" => "152" "paginaInicial" => "419" "paginaFinal" => "428" "link" => array:1 [ …1] ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib0680" "etiqueta" => "23" "referencia" => array:1 [ 0 => array:1 [ "host" => array:1 [ 0 => array:1 [ "LibroEditado" => array:4 [ "editores" => "M.B.Amin, F.L.Greene, S.B.Edge, C.C.Compton, J.E.Gershenwald, R.K.Brookland" "titulo" => "AJCC cancer staging manual" "edicion" => "8th ed." "serieFecha" => "2017" ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib0685" "etiqueta" => "24" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Metastases from squamous cell carcinoma of the skin and lip. An analysis of twenty-seven cases" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/s0190-9622(89)70168-7" "Revista" => array:7 [ "tituloSerie" => "J Am Acad Dermatol" "fecha" => "1989" "volumen" => "21" "numero" => "2 Pt 1" "paginaInicial" => "241" "paginaFinal" => "248" "link" => array:1 [ …1] ] ] ] ] ] ] 24 => array:3 [ "identificador" => "bib0690" "etiqueta" => "25" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/01.mlg.0000173202.56739.9f" "Revista" => array:6 [ "tituloSerie" => "Laryngoscope" "fecha" => "2005" "volumen" => "115" "paginaInicial" => "1561" "paginaFinal" => "1567" "link" => array:1 [ …1] ] ] ] ] ] ] 25 => array:3 [ "identificador" => "bib0695" "etiqueta" => "26" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Histopathological characteristics of metastasizing squamous cell carcinoma of the skin and lips" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1365-2559.2006.02472.x" "Revista" => array:6 [ "tituloSerie" => "Histopathology" "fecha" => "2006" "volumen" => "49" "paginaInicial" => "256" "paginaFinal" => "264" "link" => array:1 [ …1] ] ] ] ] ] ] 26 => array:3 [ "identificador" => "bib0700" "etiqueta" => "27" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cutaneous head and neck SCCs and risk of nodal metástasis—UK experience" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jcms.2009.07.007" "Revista" => array:6 [ "tituloSerie" => "J Craniomaxillofac Surg" "fecha" => "2009" "volumen" => "37" "paginaInicial" => "443" "paginaFinal" => "447" "link" => array:1 [ …1] ] ] ] ] ] ] 27 => array:3 [ "identificador" => "bib0705" "etiqueta" => "28" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Surgical management of cutaneous squamous cell carcinoma of the head and neck" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1054/bjom.2000.0584" "Revista" => array:7 [ "tituloSerie" => "Br J Oral Maxillofac Surg" "fecha" => "2001" "volumen" => "39" "paginaInicial" => "87" "paginaFinal" => "90" "link" => array:1 [ …1] "itemHostRev" => array:3 [ …3] ] ] ] ] ] ] 28 => array:3 [ "identificador" => "bib0710" "etiqueta" => "29" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Audit of clinical and histological prognostic factors in primary invasive squamous cell carcinoma of the skin: assessment in a minimum 5 year follow-up study after conventional escisional surgery" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1054/bjps.2002.3833" "Revista" => array:6 [ "tituloSerie" => "Br J Plast Surg" "fecha" => "2002" "volumen" => "55" "paginaInicial" => "287" "paginaFinal" => "292" "link" => array:1 [ …1] ] ] ] ] ] ] 29 => array:3 [ "identificador" => "bib0715" "etiqueta" => "30" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Mohs surgery is effective for high-risk cutaneous squamous cell carcinoma" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1524-4725.2010.01576.x" "Revista" => array:6 [ "tituloSerie" => "Dermatol Surg" "fecha" => "2010" "volumen" => "36" "paginaInicial" => "1544" "paginaFinal" => "1553" "link" => array:1 [ …1] ] ] ] ] ] ] 30 => array:3 [ "identificador" => "bib0720" "etiqueta" => "31" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Association of nodal metastasis and mortality with vermilion vs cutaneous lip location in cutaneous squamous cell carcinoma of the lip" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/jamadermatol.2018.0792" "Revista" => array:6 [ "tituloSerie" => "JAMA Dermatol" "fecha" => "2018" "volumen" => "154" "paginaInicial" => "701" "paginaFinal" => "707" "link" => array:1 [ …1] ] ] ] ] ] ] 31 => array:3 [ "identificador" => "bib0725" "etiqueta" => "32" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "National Comprehensive Cancer Network. Squamous cell skin cancer (Version 1.2019). Available from: <a target="_blank" href="http://www.nccn.org/professionals/physician_gls/pdf/bone.pdf">http://www.nccn.org/professionals/physician_gls/pdf/bone.pdf</a> [accessed 10.01.19]" ] ] ] 32 => array:3 [ "identificador" => "bib0730" "etiqueta" => "33" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Acute epitelioma—an aggressive squamous cell carcinoma of the skin" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/00000421-198512000-00004" "Revista" => array:6 [ "tituloSerie" => "Am J Clin Oncol" "fecha" => "1985" "volumen" => "8" "paginaInicial" => "468" "paginaFinal" => "471" "link" => array:1 [ …1] ] ] ] ] ] ] 33 => array:3 [ "identificador" => "bib0735" "etiqueta" => "34" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Rapid growth rate is associated with poor prognosis in cutaneous squamous cell carcinoma" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/ced.13570" "Revista" => array:6 [ "tituloSerie" => "Clin Exp Dermatol" "fecha" => "2018" "volumen" => "43" "paginaInicial" => "876" "paginaFinal" => "882" "link" => array:1 [ …1] ] ] ] ] ] ] 34 => array:3 [ "identificador" => "bib0740" "etiqueta" => "35" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "What is the role of adjuvant radiotherapy in the treatment of cutaneous squamous cell carcinoma with perineural invasion?" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/cncr.22509" "Revista" => array:6 [ "tituloSerie" => "Cancer" "fecha" => "2007" "volumen" => "109" "paginaInicial" => "1053" "paginaFinal" => "1059" "link" => array:1 [ …1] ] ] ] ] ] ] 35 => array:3 [ "identificador" => "bib0745" "etiqueta" => "36" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pain identifies squamous cell carcinoma in organ transplant recipients: the SCOPE-ITSCC PAIN study" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/ajt.12587" "Revista" => array:6 [ "tituloSerie" => "Am J Transplant" "fecha" => "2014" "volumen" => "14" "paginaInicial" => "668" "paginaFinal" => "676" "link" => array:1 [ …1] ] ] ] ] ] ] 36 => array:3 [ "identificador" => "bib0750" "etiqueta" => "37" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Aggressive cutaneous malignancies following cardiothoracic transplantation: the Australian experience" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Cancer" "fecha" => "1999" "volumen" => "85" "paginaInicial" => "1758" "paginaFinal" => "1764" "link" => array:1 [ …1] ] ] ] ] ] ] 37 => array:3 [ "identificador" => "bib0755" "etiqueta" => "38" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Increased metástasis and mortality from cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jaad.2005.08.055" "Revista" => array:6 [ "tituloSerie" => "J Am Acad Dermatol" "fecha" => "2005" "volumen" => "53" "paginaInicial" => "1067" "paginaFinal" => "1071" "link" => array:1 [ …1] ] ] ] ] ] ] 38 => array:3 [ "identificador" => "bib0760" "etiqueta" => "39" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Skin cancer and cyclosporine therapy" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "N Engl J Med" "fecha" => "1985" "volumen" => "313" "paginaInicial" => "1420" "link" => array:1 [ …1] ] ] ] ] ] ] 39 => array:3 [ "identificador" => "bib0765" "etiqueta" => "40" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Azathioprine treatment photosensitizes human skin to ultraviolet A radiation" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1365-2133.2008.08610.x" "Revista" => array:6 [ "tituloSerie" => "Br J Dermatol" "fecha" => "2008" "volumen" => "159" "paginaInicial" => "198" "paginaFinal" => "204" "link" => array:1 [ …1] ] ] ] ] ] ] 40 => array:3 [ "identificador" => "bib0770" "etiqueta" => "41" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Azathioprine and UVA light generate mutagenic oxidative DNA damage" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1126/science.1114233" "Revista" => array:6 [ "tituloSerie" => "Science" "fecha" => "2005" "volumen" => "309" "paginaInicial" => "1871" "paginaFinal" => "1874" "link" => array:1 [ …1] ] ] ] ] ] ] 41 => array:3 [ "identificador" => "bib0775" "etiqueta" => "42" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Suboptimal outcomes in cutaneous squamous cell cancer of the head and neck with nodal metastases" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.21873/anticanres.12923" "Revista" => array:6 [ "tituloSerie" => "Anticancer Res" "fecha" => "2018" "volumen" => "38" "paginaInicial" => "5825" "paginaFinal" => "5830" "link" => array:1 [ …1] ] ] ] ] ] ] 42 => array:3 [ "identificador" => "bib0780" "etiqueta" => "43" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Skin cancers after organ transplantation" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMra022137" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2003" "volumen" => "348" "paginaInicial" => "1681" "paginaFinal" => "1691" "link" => array:1 [ …1] ] ] ] ] ] ] 43 => array:3 [ "identificador" => "bib0785" "etiqueta" => "44" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Subsequent skin cancers in kidney and heart transplant recipients after the first squamous cell carcinoma" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/01.tp.0000209921.60305.d9" "Revista" => array:6 [ "tituloSerie" => "Transplantation" "fecha" => "2006" "volumen" => "81" "paginaInicial" => "1093" "paginaFinal" => "1100" "link" => array:1 [ …1] ] ] ] ] ] ] 44 => array:3 [ "identificador" => "bib0790" "etiqueta" => "45" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Aggressive squamous cell carcinoma in organ transplant recipients" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/jamadermatol.2018.4406" "Revista" => array:6 [ "tituloSerie" => "JAMA Dermatol" "fecha" => "2019" "volumen" => "155" "paginaInicial" => "66" "paginaFinal" => "71" "link" => array:1 [ …1] ] ] ] ] ] ] 45 => array:3 [ "identificador" => "bib0795" "etiqueta" => "46" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Metastatic cutaneous squamous cell carcinoma: the importance of T2 stratification and hematologic malignancy in prognostication" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/DSS.0000000000000798" "Revista" => array:6 [ "tituloSerie" => "Dermatol Surg" "fecha" => "2016" "volumen" => "42" "paginaInicial" => "932" "paginaFinal" => "935" "link" => array:1 [ …1] ] ] ] ] ] ] 46 => array:3 [ "identificador" => "bib0800" "etiqueta" => "47" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Recurrence after treatment of cutaneous basal cell and squamous cell carcinomas in patients infected with human immunodeficiency virus" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/2013.jamadermatol.245" "Revista" => array:6 [ "tituloSerie" => "JAMA Dermatol" "fecha" => "2013" "volumen" => "149" "paginaInicial" => "239" "paginaFinal" => "241" "link" => array:1 [ …1] ] ] ] ] ] ] 47 => array:3 [ "identificador" => "bib0805" "etiqueta" => "48" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Squamous cell carcinoma developing on burn scar" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/01.sap.0000200734.74303.d5" "Revista" => array:6 [ "tituloSerie" => "Ann Plast Surg" "fecha" => "2006" "volumen" => "56" "paginaInicial" => "406" "paginaFinal" => "408" "link" => array:1 [ …1] ] ] ] ] ] ] 48 => array:3 [ "identificador" => "bib0810" "etiqueta" => "49" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Burn scar neoplasms: a literature review and statistical analysis" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Burns" "fecha" => "2005" "volumen" => "31" "paginaInicial" => "403" "paginaFinal" => "413" ] ] ] ] ] ] 49 => array:3 [ "identificador" => "bib0815" "etiqueta" => "50" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Radiation-induced skin cancer of the head and neck" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/1097-0142(197001)25:1<61::aid-cncr2820250110>3.0.co;2-w" "Revista" => array:6 [ "tituloSerie" => "Cancer" "fecha" => "1970" "volumen" => "25" "paginaInicial" => "61" "paginaFinal" => "71" "link" => array:1 [ …1] ] ] ] ] ] ] 50 => array:3 [ "identificador" => "bib0820" "etiqueta" => "51" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Squamous cell carcinoma arising in previously burned or irradiated skin" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/archsurg.1989.01410010125024" "Revista" => array:6 [ "tituloSerie" => "Arch Surg" "fecha" => "1989" "volumen" => "124" "paginaInicial" => "115" "paginaFinal" => "117" "link" => array:1 [ …1] ] ] ] ] ] ] 51 => array:3 [ "identificador" => "bib0825" "etiqueta" => "52" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Management of cutaneous squamous cell carcinoma in patients with epidermolysis bullosa: best clinical practice guidelines" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/bjd.14104" "Revista" => array:6 [ "tituloSerie" => "Br J Dermatol" "fecha" => "2016" "volumen" => "174" "paginaInicial" => "56" "paginaFinal" => "67" "link" => array:1 [ …1] ] ] ] ] ] ] 52 => array:3 [ "identificador" => "bib0830" "etiqueta" => "53" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cancer and neurologic degeneration in xeroderma pigmentosum: long term follow-up characterises the role of DNA repair" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Med Genet" "fecha" => "2011" "volumen" => "48" "paginaInicial" => "168" "paginaFinal" => "176" ] ] ] ] ] ] 53 => array:3 [ "identificador" => "bib0835" "etiqueta" => "54" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Xeroderma pigmentosum: diagnostic procedures, interdisciplinary patient care, and novel therapeutic approaches" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/ddg.12419" "Revista" => array:6 [ "tituloSerie" => "J Dtsch Dermatol Ges" "fecha" => "2014" "volumen" => "12" "paginaInicial" => "867" "paginaFinal" => "872" "link" => array:1 [ …1] ] ] ] ] ] ] 54 => array:3 [ "identificador" => "bib0840" "etiqueta" => "55" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Oculocutaneous albinism and squamous cell carcinoma of the skin of the head and neck in Sub-Saharan Africa" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1155/2015/167847" "Revista" => array:5 [ "tituloSerie" => "J Skin Cancer" "fecha" => "2015" "volumen" => "2015" "paginaInicial" => "167847" "link" => array:1 [ …1] ] ] ] ] ] ] 55 => array:3 [ "identificador" => "bib0845" "etiqueta" => "56" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Oculocutaneous albinism" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/1750-1172-2-43" "Revista" => array:5 [ "tituloSerie" => "Orphanet J Rare Dis" "fecha" => "2007" "volumen" => "2" "paginaInicial" => "43" "link" => array:1 [ …1] ] ] ] ] ] ] 56 => array:3 [ "identificador" => "bib0850" "etiqueta" => "57" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Bloom's syndrome: clinical spectrum molecular pathogenesis, and cancer predisposition" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1159/000452082" "Revista" => array:6 [ "tituloSerie" => "Mol Syndromol" "fecha" => "2017" "volumen" => "8" "paginaInicial" => "4" "paginaFinal" => "23" "link" => array:1 [ …1] ] ] ] ] ] ] 57 => array:3 [ "identificador" => "bib0855" "etiqueta" => "58" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Multiple cutaneous neoplasms in a patient with Rothmund-Thomson syndrome: case report and published work review" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1346-8138.2008.00436.x" "Revista" => array:6 [ "tituloSerie" => "J Dermatol" "fecha" => "2008" "volumen" => "35" "paginaInicial" => "154" "paginaFinal" => "161" "link" => array:1 [ …1] ] ] ] ] ] ] 58 => array:3 [ "identificador" => "bib0860" "etiqueta" => "59" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Rothmund-Thomson syndrome" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/1750-1172-5-2" "Revista" => array:5 [ "tituloSerie" => "Orphanet J Rare Dis" "fecha" => "2010" "volumen" => "5" "paginaInicial" => "2" "link" => array:1 [ …1] ] ] ] ] ] ] 59 => array:3 [ "identificador" => "bib0865" "etiqueta" => "60" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "“Rewritten in the skin”: clues to skin biology and aging from inherited disease" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/jid.2015.88" "Revista" => array:6 [ "tituloSerie" => "J Invest Dermatol" "fecha" => "2015" "volumen" => "135" "paginaInicial" => "1484" "paginaFinal" => "1490" "link" => array:1 [ …1] ] ] ] ] ] ] 60 => array:3 [ "identificador" => "bib0870" "etiqueta" => "61" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Malignant skin tumours in patients with inherited ichthyosis" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1365-2133.2011.10381.x" "Revista" => array:6 [ "tituloSerie" => "Br J Dermatol" "fecha" => "2011" "volumen" => "165" "paginaInicial" => "263" "paginaFinal" => "268" "link" => array:1 [ …1] ] ] ] ] ] ] 61 => array:3 [ "identificador" => "bib0875" "etiqueta" => "62" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Keratitis, ichthyosis, and deafness syndrome: a review of infectious and neoplastic complications" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Am Acad Dermatol" "fecha" => "2013" "volumen" => "69" "paginaInicial" => "127" "paginaFinal" => "134" ] ] ] ] ] ] 62 => array:3 [ "identificador" => "bib0880" "etiqueta" => "63" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Multiple self-healing squamous epithelioma (MSSE): rare variants in an adjacent region of chromosome 9q22.3 to known TGFBR1 mutations suggest a digenic or multilocus etiology" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/jid.2013.45" "Revista" => array:6 [ "tituloSerie" => "J Invest Dermatol" "fecha" => "2013" "volumen" => "133" "paginaInicial" => "1907" "paginaFinal" => "1910" "link" => array:1 [ …1] ] ] ] ] ] ] 63 => array:3 [ "identificador" => "bib0885" "etiqueta" => "64" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Multiple self-healing squamous epithelioma is caused by a disease-specific spectrum of mutations in TGFBR1" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/ng.780" "Revista" => array:6 [ "tituloSerie" => "Nat Genet" "fecha" => "2011" "volumen" => "43" "paginaInicial" => "365" "paginaFinal" => "369" "link" => array:1 [ …1] ] ] ] ] ] ] 64 => array:3 [ "identificador" => "bib0890" "etiqueta" => "65" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Muir-Torre syndrome" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S1470-2045(05)70465-4" "Revista" => array:6 [ "tituloSerie" => "Lancet Oncol" "fecha" => "2005" "volumen" => "6" "paginaInicial" => "980" "paginaFinal" => "987" "link" => array:1 [ …1] ] ] ] ] ] ] 65 => array:3 [ "identificador" => "bib0895" "etiqueta" => "66" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Epidermodysplasia verruciformis" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1159/000356068" "Revista" => array:6 [ "tituloSerie" => "Curr Probl Dermatol" "fecha" => "2014" "volumen" => "45" "paginaInicial" => "123" "paginaFinal" => "131" "link" => array:1 [ …1] ] ] ] ] ] ] 66 => array:3 [ "identificador" => "bib0900" "etiqueta" => "67" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Familial skin cancer syndromes: increased risk of nonmelanotic skin cancers and extracutaneous tumors" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jaad.2015.08.073" "Revista" => array:6 [ "tituloSerie" => "J Am Acad Dermatol" "fecha" => "2016" "volumen" => "74" "paginaInicial" => "437" "paginaFinal" => "451" "link" => array:1 [ …1] ] ] ] ] ] ] 67 => array:3 [ "identificador" => "bib0905" "etiqueta" => "68" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Skin cancer associated genodermatoses: a literature review" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2340/00015555-3123" "Revista" => array:6 [ "tituloSerie" => "Acta Derm Venereol" "fecha" => "2019" "volumen" => "99" "paginaInicial" => "360" "paginaFinal" => "369" "link" => array:1 [ …1] ] ] ] ] ] ] 68 => array:3 [ "identificador" => "bib0910" "etiqueta" => "69" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prognostic and therapeutic use of microstaging of cutaneous squamous cell carcinoma of the trunk and extremities" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/1097-0142(19850901)56:5<1099::aid-cncr2820560524>3.0.co;2-r" "Revista" => array:6 [ "tituloSerie" => "Cancer" "fecha" => "1985" "volumen" => "56" "paginaInicial" => "1099" "paginaFinal" => "1105" "link" => array:1 [ …1] ] ] ] ] ] ] 69 => array:3 [ "identificador" => "bib0915" "etiqueta" => "70" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Histologic correlates of metástasis in primary invasive squamous cell carcinoma of the lip" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1600-0560.1994.tb00685.x" "Revista" => array:6 [ "tituloSerie" => "J Cutan Pathol" "fecha" => "1994" "volumen" => "21" "paginaInicial" => "16" "paginaFinal" => "21" "link" => array:1 [ …1] ] ] ] ] ] ] 70 => array:3 [ "identificador" => "bib0920" "etiqueta" => "71" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cutaneous squamous cell carcinoma (SCC) of the head and neck: risk factors of overall and recurrence-free survival" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ejca.2010.02.046" "Revista" => array:6 [ "tituloSerie" => "Eur J Cancer" "fecha" => "2010" "volumen" => "46" "paginaInicial" => "1563" "paginaFinal" => "1572" "link" => array:1 [ …1] ] ] ] ] ] ] 71 => array:3 [ "identificador" => "bib0925" "etiqueta" => "72" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinical and histological prognostic factors for local recurrence and metástasis of cutaneous squamous cell carcinoma: analysis of a defined population" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2340/00015555-1501" "Revista" => array:6 [ "tituloSerie" => "Acta Derm Venereol" "fecha" => "2012" "volumen" => "93" "paginaInicial" => "417" "paginaFinal" => "421" "link" => array:1 [ …1] ] ] ] ] ] ] 72 => array:3 [ "identificador" => "bib0930" "etiqueta" => "73" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "High recurrence rates of squamous cell carcinoma after Mohs’ surgery in patients with chronic lymphocytic leukemia" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1524-4725.2005.31006" "Revista" => array:6 [ "tituloSerie" => "Dermatol Surg" "fecha" => "2005" "volumen" => "31" "paginaInicial" => "38" "paginaFinal" => "42" "link" => array:1 [ …1] ] ] ] ] ] ] 73 => array:3 [ "identificador" => "bib0935" "etiqueta" => "74" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Invasive squamous cell carcinoma of the skin: defining a high-risk group" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1245/ASO.2006.07.022" "Revista" => array:6 [ "tituloSerie" => "Ann Surg Oncol" "fecha" => "2006" "volumen" => "13" "paginaInicial" => "902" "paginaFinal" => "909" "link" => array:1 [ …1] ] ] ] ] ] ] 74 => array:3 [ "identificador" => "bib0940" "etiqueta" => "75" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The 7th edition AJCC staging system for cutaneous squamous cell carcinoma accurately predicts risk of recurrence for heart and lung transplant recipients" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jaad.2012.01.010" "Revista" => array:6 [ "tituloSerie" => "J Am Acad Dermatol" "fecha" => "2012" "volumen" => "67" "paginaInicial" => "829" "paginaFinal" => "835" "link" => array:1 [ …1] ] ] ] ] ] ] 75 => array:3 [ "identificador" => "bib0945" "etiqueta" => "76" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The incidence of metástasis from cutaneous squamous cell carcinoma and the impact of its risk factors" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/jso.23155" "Revista" => array:6 [ "tituloSerie" => "J Surg Oncol" "fecha" => "2012" "volumen" => "106" "paginaInicial" => "811" "paginaFinal" => "815" "link" => array:1 [ …1] ] ] ] ] ] ] 76 => array:3 [ "identificador" => "bib0950" "etiqueta" => "77" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Risk stratification for metástasis from cutaneous squamous cell carcinoma of the head and neck" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1445-2197.2011.05994.x" "Revista" => array:6 [ "tituloSerie" => "ANZ J Surg" "fecha" => "2012" "volumen" => "82" "paginaInicial" => "230" "paginaFinal" => "233" "link" => array:1 [ …1] ] ] ] ] ] ] 77 => array:3 [ "identificador" => "bib0955" "etiqueta" => "78" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The effect of differentiation grade of cutaneous squamous cell carcinoma on excision margins, local recurrence metastasis, and patient survival: a retrospective follow-up study" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/SAP.0000000000000110" "Revista" => array:6 [ "tituloSerie" => "Ann Plast Surg" "fecha" => "2015" "volumen" => "75" "paginaInicial" => "323" "paginaFinal" => "326" "link" => array:1 [ …1] ] ] ] ] ] ] 78 => array:3 [ "identificador" => "bib0960" "etiqueta" => "79" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Invasive head and neck cutaneous squamous cell carcinoma: clinical and histopathological characteristics, frequency of local recurrence and metástasis" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1590/abd1806-4841.20142810" "Revista" => array:7 [ "tituloSerie" => "An Bras Dermatol" "fecha" => "2014" "volumen" => "89" "paginaInicial" => "562" "paginaFinal" => "568" "link" => array:1 [ …1] "itemHostRev" => array:3 [ …3] ] ] ] ] ] ] 79 => array:3 [ "identificador" => "bib0965" "etiqueta" => "80" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The value of adjuvant radiotherapy in cutaneous squamous cell carcinoma: a review" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ad.2018.03.007" "Revista" => array:6 [ "tituloSerie" => "Actas Dermosifiliogr" "fecha" => "2018" "volumen" => "109" "paginaInicial" => "476" "paginaFinal" => "484" "link" => array:1 [ …1] ] ] ] ] ] ] 80 => array:3 [ "identificador" => "bib0970" "etiqueta" => "81" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Perineural invasion and perineural tumor spread in head and neck cancer: a critical review" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ijrobp.2018.12.009" "Revista" => array:6 [ "tituloSerie" => "Int J Radiat Oncol Biol Phys" "fecha" => "2019" "volumen" => "103" "paginaInicial" => "1109" "paginaFinal" => "1124" "link" => array:1 [ …1] ] ] ] ] ] ] 81 => array:3 [ "identificador" => "bib0975" "etiqueta" => "82" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prognostic factors in squamous cell carcinoma of the lower lip" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/s0046-8177(86)80457-9" "Revista" => array:7 [ "tituloSerie" => "Hum Pathol" …6 ] ] ] ] ] ] 82 => array:3 [ "identificador" => "bib0980" "etiqueta" => "83" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Sclerosing squamous cell carcinoma of the skin, an underemphasized locally aggressive variant: a 20-year experience" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1524-4725.2010.01850.x" "Revista" => array:6 [ …6] ] ] ] ] ] 83 => array:3 [ "identificador" => "bib0985" "etiqueta" => "84" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Desmoplastic squamous cell carcinoma of skin and vermilion surface: a highly malignant subtype of skin cancer" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/(sici)1097-0142(19970301)79:5<915::aid-cncr7>3.0.co;2-a" "Revista" => array:6 [ …6] ] ] ] ] ] 84 => array:3 [ "identificador" => "bib0990" "etiqueta" => "85" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Tumor budding is an independent risk factor for lymph node metástasis in cutaneous squamous cell carcinoma: a single center retrospective study" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/cup.12740" "Revista" => array:6 [ …6] ] ] ] ] ] 85 => array:3 [ "identificador" => "bib0995" "etiqueta" => "86" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The adverse prognostic effect of tumor budding on the evolution of cutaneous head and neck squamous cell carcinoma" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jaad.2017.01.015" "Revista" => array:6 [ …6] ] ] ] ] ] 86 => array:3 [ "identificador" => "bib1000" "etiqueta" => "87" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prognostic significance of tumor budding in cutaneous squamous cell carcinoma" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jaad.2017.07.060" "Revista" => array:5 [ …5] ] ] ] ] ] 87 => array:3 [ "identificador" => "bib1005" "etiqueta" => "88" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Adenoid squamous cell carcinoma (adenoacanthoma). A clinicopathologic study of 155 patients" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/1097-0142(196611)19:11<1639::aid-cncr2820191131>3.0.co;2-n" "Revista" => array:6 [ …6] ] ] ] ] ] 88 => array:3 [ "identificador" => "bib1010" "etiqueta" => "89" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Adenoid (acantholytic) squamous cell carcinoma of the skin" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1600-0560.1989.tb00024.x" "Revista" => array:6 [ …6] ] ] ] ] ] 89 => array:3 [ "identificador" => "bib1015" "etiqueta" => "90" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Adenosquamous carcinoma of the skin: a report of 10 cases" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1600-0560.1991.tb01228.x" "Revista" => array:6 [ …6] ] ] ] ] ] 90 => array:3 [ "identificador" => "bib1020" "etiqueta" => "91" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Acantholytic squamous cell carcinoma is usually associated with hair follicles, not acantholytic actinic keratosis, and is not “high risk”: diagnosis, management, and clinical outcomes in a series of 115 cases" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jaad.2016.09.024" "Revista" => array:6 [ …6] ] ] ] ] ] 91 => array:3 [ "identificador" => "bib1025" "etiqueta" => "92" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Epidermal growth factor receptor expression is associated with poor outcome in cutaneous squamous cell carcinoma" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/bjd.14936" "Revista" => array:6 [ …6] ] ] ] ] ] 92 => array:3 [ "identificador" => "bib1030" "etiqueta" => "93" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Epidermal growth factor receptor: a novel biomarker for aggressive head and neck cutaneous squamous cell carcinoma" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.humpath.2007.07.004" "Revista" => array:6 [ …6] ] ] ] ] ] 93 => array:3 [ "identificador" => "bib1035" "etiqueta" => "94" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The expression of podoplanin is associated with poor outcome in cutaneous squamous cell carcinoma" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/cup.12859" "Revista" => array:6 [ …6] ] ] ] ] ] 94 => array:3 [ "identificador" => "bib1040" "etiqueta" => "95" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "D2-40 immunohistochemical overexpression in cutaneous squamous cell carcinomas: a marker of metastatic risk" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jaad.2012.03.007" "Revista" => array:6 [ …6] ] ] ] ] ] 95 => array:3 [ "identificador" => "bib1045" "etiqueta" => "96" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Epithelial to mesenchymal transition markers are associated with an increased metastatic risk in primary cutaneous squamous cell carcinomas but are attenuated in lymph node metastases" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jdermsci.2013.07.001" "Revista" => array:6 [ …6] ] ] ] ] ] 96 => array:3 [ "identificador" => "bib1050" "etiqueta" => "97" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "PD-L1 expression is increased in metastasizing squamous cell carcinomas and their metastases" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/DAD.0000000000001164" "Revista" => array:6 [ …6] ] ] ] ] ] 97 => array:3 [ "identificador" => "bib1055" "etiqueta" => "98" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Tumor programmed cell death ligand 1 expression correlates with nodal metastasis in patients with cutaneous squamous cell carcinoma of the head and neck" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jaad.2017.05.047" "Revista" => array:6 [ …6] ] ] ] ] ] 98 => array:3 [ "identificador" => "bib1060" "etiqueta" => "99" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "PD-L1 expression in cutaneous squamous cell carcinoma correlates with risk of metástasis" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/cup.12728" "Revista" => array:6 [ …6] ] ] ] ] ] 99 => array:3 [ "identificador" => "bib1065" "etiqueta" => "100" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Evaluation of American Joint Committee on Cancer International Union Against Cancer, and Brigham and Women's Hospital tumor staging for cutaneous squamous cell carcinoma" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1200/JCO.2012.48.5326" "Revista" => array:6 [ …6] ] ] ] ] ] 100 => array:3 [ "identificador" => "bib1070" "etiqueta" => "101" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Comparison of tumor classifications for cutaneous squamous cell carcinoma of the head and neck in the 7th vs 8th edition of the AJCC Cancer Staging Manual" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/jamadermatol.2017.3960" "Revista" => array:6 [ …6] ] ] ] ] ] 101 => array:3 [ "identificador" => "bib1075" "etiqueta" => "102" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Comparing the eighth and the seventh editions of the American Joint Committee on Cancer staging system and the Brigham and Women's Hospital alternative staging system for cutaneous squamous cell carcinoma: implications for clinical practice" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jaad.2018.06.060" "Revista" => array:6 [ …6] ] ] ] ] ] 102 => array:3 [ "identificador" => "bib1080" "etiqueta" => "103" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Advanced cutaneous squamous cell carcinoma: a retrospective analysis of patient profiles and treatment patterns – results of a non-interventional study of the DeCOG" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ejca.2018.01.075" "Revista" => array:6 [ …6] ] ] ] ] ] 103 => array:3 [ "identificador" => "bib1085" "etiqueta" => "104" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Efficacy and safety of vismodegib in advanced basal-cell carcinoma" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMoa1113713" "Revista" => array:6 [ …6] ] ] ] ] ] 104 => array:3 [ "identificador" => "bib1090" "etiqueta" => "105" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "PD-1 blockade with cemiplimab in advanced cutaneous squamous-cell carcinoma" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMoa1805131" "Revista" => array:6 [ …6] ] ] ] ] ] 105 => array:3 [ "identificador" => "bib1095" "etiqueta" => "106" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "In-transit metastasis from squamous cell carcinoma" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/DSS.0000000000000864" "Revista" => array:7 [ …7] ] ] ] ] ] 106 => array:3 [ "identificador" => "bib1100" "etiqueta" => "107" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Novel additions to the AJCC's New Staging Systems for Skin Cancer" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ad.2017.05.012" "Revista" => array:6 [ …6] ] ] ] ] ] 107 => array:3 [ "identificador" => "bib1105" "etiqueta" => "108" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Metastatic cutaneous squamous cell carcinoma: an update" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1524-4725.2007.33190.x" "Revista" => array:6 [ …6] ] ] ] ] ] 108 => array:3 [ "identificador" => "bib1110" "etiqueta" => "109" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Nationwide incidence of metastatic cutaneous squamous cell carcinoma in England" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/jamadermatol.2018.4219" "Revista" => array:6 [ …6] ] ] ] ] ] 109 => array:3 [ "identificador" => "bib1115" "etiqueta" => "110" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ejca.2015.06.110" "Revista" => array:6 [ …6] ] ] ] ] ] 110 => array:3 [ "identificador" => "bib1120" "etiqueta" => "111" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Systematic review of the prevalence of nodal metastases and the prognostic utility of sentinel lymph node biopsy in cutaneous squamous cell carcinoma" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/1346-8138.14342" "Revista" => array:7 [ …7] ] ] ] ] ] 111 => array:3 [ "identificador" => "bib1125" "etiqueta" => "112" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cutaneous head and neck squamous cell carcinoma metastatic to cervical lymph nodes (nonparotid): a better outcome with surgery and adjuvant radiotherapy" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/00005537-200310000-00031" "Revista" => array:6 [ …6] ] ] ] ] ] 112 => array:3 [ "identificador" => "bib1130" "etiqueta" => "113" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Surgery and adjuvant radiotherapy in patients with cutaneous head and neck squamous cell carcinoma metastatic to lymph nodes: combined treatment should be considered best practice" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/01.MLG.0000158349.64337.ED" "Revista" => array:6 [ …6] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/15782190/0000011100000004/v1_202006060751/S1578219020301232/v1_202006060751/en/main.assets" "Apartado" => array:4 [ "identificador" => "6150" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Review" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/15782190/0000011100000004/v1_202006060751/S1578219020301232/v1_202006060751/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219020301232?idApp=UINPBA000044" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 14 | 14 | 28 |
2024 October | 73 | 72 | 145 |
2024 September | 84 | 42 | 126 |
2024 August | 104 | 53 | 157 |
2024 July | 80 | 39 | 119 |
2024 June | 99 | 50 | 149 |
2024 May | 108 | 34 | 142 |
2024 April | 99 | 41 | 140 |
2024 March | 107 | 50 | 157 |
2024 February | 71 | 35 | 106 |
2024 January | 83 | 35 | 118 |
2023 December | 61 | 15 | 76 |
2023 November | 83 | 39 | 122 |
2023 October | 92 | 36 | 128 |
2023 September | 88 | 34 | 122 |
2023 August | 70 | 15 | 85 |
2023 July | 68 | 38 | 106 |
2023 June | 39 | 19 | 58 |
2023 May | 71 | 21 | 92 |
2023 April | 50 | 28 | 78 |
2023 March | 96 | 33 | 129 |
2023 February | 63 | 27 | 90 |
2023 January | 64 | 40 | 104 |
2022 December | 76 | 29 | 105 |
2022 November | 61 | 39 | 100 |
2022 October | 37 | 37 | 74 |
2022 September | 36 | 41 | 77 |
2022 August | 22 | 42 | 64 |
2022 July | 28 | 37 | 65 |
2022 June | 25 | 32 | 57 |
2022 May | 68 | 28 | 96 |
2022 April | 72 | 46 | 118 |
2022 March | 83 | 52 | 135 |
2022 February | 60 | 41 | 101 |
2022 January | 80 | 56 | 136 |
2021 December | 88 | 43 | 131 |
2021 November | 76 | 55 | 131 |
2021 October | 68 | 56 | 124 |
2021 September | 46 | 39 | 85 |
2021 August | 41 | 32 | 73 |
2021 July | 32 | 10 | 42 |
2021 June | 33 | 37 | 70 |
2021 May | 25 | 39 | 64 |
2021 April | 75 | 67 | 142 |
2021 March | 124 | 33 | 157 |
2021 February | 140 | 22 | 162 |
2021 January | 77 | 17 | 94 |
2020 December | 53 | 21 | 74 |
2020 November | 29 | 13 | 42 |
2020 October | 32 | 21 | 53 |
2020 September | 57 | 21 | 78 |
2020 August | 212 | 28 | 240 |
2020 July | 95 | 31 | 126 |
2020 June | 110 | 56 | 166 |
2020 May | 24 | 11 | 35 |